Biomolecular Targets of Oxyprenylated Phenylpropanoids and Polyketides.

Serena Fiorito, Francesco Epifano, Francesca Preziuso, Vito Alessandro Taddeo, Salvatore Genovese

Journal: Progress in the chemistry of organic natural products 2019;108():143-205

PMID: 30924014

Abstract

Oxyprenylated secondary metabolites (e.g. phenylpropanoids and polyketides) represent a rare class of natural compounds. Over the past two decades, this group of phytochemicals has become a topic of intense research activity by several teams worldwide due to their in vitro and in vivo pharmacological activities, and to their great therapeutic and nutraceutical potential for the chemoprevention of acute and chronic diseases affecting humans. Such investigations have provided evidence that oxyprenylated secondary metabolites are able to interact with several biological targets at different levels accounting for their observed anticarcinogenic, anti-inflammatory, neuroprotective, immunomodulatory, antihypertensive, and metabolic effects. The aim of the present contribution is to provide a detailed survey of the so far reported data on the capacities of selected oxyprenylated phenylpropanoids and polyketides to trigger receptors, enzymes, and other types of cellular factors for which they exhibit a high degree of affinity and therefore evoke specific responses. With respect to the rather small amounts of these compounds available from natural sources, their chemical synthesis is also highlighted.

Address: Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Chieti Scalo, Italy.; Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Chieti Scalo, Italy. [email protected].

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.